Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke

Digital Intervention Based on BCW Theory Has a High Blood Pressure in High-risk Population of Stroke Study on the Effect of Stress on Self-management Behavior of Patients

Stroke is the second leading cause of death in the world, and the number of stroke patients in China ranks the first in the world. Hypertension is the most important risk factor. Studies have shown that 80% of stroke can be prevented by controlling risk factors. However, the management level of hypertension patients in China is still low, and their self-management ability is insufficient.

Digital health management, such as remote monitoring, AI and mobile health platforms, provides a new way for hypertension prevention and control. Foreign studies have shown that digital interventions can effectively improve patients' self-management behaviors, such as diet, exercise and blood pressure control. Interventions based on wechat, APP and other tools in China have also achieved positive results, but face challenges such as patient acceptance, system adaptation and data continuity.

Based on behavior change wheel (BCW) theory ** and digital platform, this study formulated personalized intervention programs for hypertension patients in high-risk groups of stroke, and promoted health behavior change from three aspects of ** ability, motivation and opportunity **. By improving disease cognition and strengthening self-management, the incidence of stroke can be ultimately reduced, and a new strategy for hypertension prevention and control in the community can be provided.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion criteria:

(1) hypertensive patients at high risk of stroke screened in the National Screening and Intervention Project for High-risk Population of Stroke (2) willing to participate Cooperate and sign the informed consent form

Exclusion criteria:

(1) TIA and stroke patients (2) severe cognitive impairment (MMSE≤9) and (3) inability to use smartphones (4) Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Digital intervention has a high blood pressure in the high-risk population of stroke Study
The chronic disease management App developed by the Affiliated Hospital of Nantong University was used to digitally manage hypertension patients, construct personalized intervention programs for such patients, and implement effective supervision and management on the platform. By strengthening the cognition of the population on the disease, it can increase their ability to self-management health, promote the change of health behavior, and ultimately reduce the incidence of stroke

Intervention group (n = 60) : Interventions were developed for five behavioral problems, as follows:

  1. Lack of knowledge about hypertension

    - Measures: APP push knowledge (risk factors, medication, lifestyle, etc.), blood pressure monitoring teaching, monthly online lectures, regular feedback and encouragement of blood pressure data.

  2. Poor medication compliance

    - Measures: Medication reminders were set by the APP, and repeated and recorded when no medication was taken.

  3. Obesity/overweight Targets: BMI 18.5-23.9, waist circumference <90cm in men and <85cm in women Interventions: promoting knowledge about the dangers of obesity, daily exercise reminders, setting weight loss goals and encouraging weight loss.
  4. A high-sodium diet Target: <6g salt per day

    - Measures: Release of low-salt dietary guidelines (graphic and text) and distribution of salt-limiting spoons (1-2 grams).

  5. Drinking too much Target: ≤25g alcohol per day for men and ≤15g for women; Weekly male ≤140g, female ≤80
No Intervention: The control group was given health education according to the community management routine of the 20
Patients in the control group will receive routine hypertension management in the community according to the recommendations of the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024), including health education, lifestyle intervention, blood pressure monitoring, and regular follow-up **, but without the use of digital chronic disease management App.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hypertension Self-Management Behavior Rating Scale (HPSMBRS)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Hypertension Knowledge Scale (HK-LS)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Stroke premonitory symptom alertness assessment questionnaire
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Self-rating Depression Scale (PHQ-9)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Generalized Anxiety Disorder-7 (GAD-7)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood Pressure (mmHg)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Blood lipid (mmol/L)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Fasting blood glucose (mmol/L)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Glycosylated hemoglobin (HbA1c)(%)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Blood homocysteine (Hcy) (mmol/L)
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later
Is the risk of stroke reduced? : Risk prediction for atherosclerotic cardiovascular disease in China Prediction for ASCVD Risk in China, China-PAR
Time Frame: From the beginning of enrollment to the end 6 months later
From the beginning of enrollment to the end 6 months later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2025

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 10, 2026

Study Registration Dates

First Submitted

July 22, 2025

First Submitted That Met QC Criteria

July 22, 2025

First Posted (Actual)

July 28, 2025

Study Record Updates

Last Update Posted (Actual)

July 28, 2025

Last Update Submitted That Met QC Criteria

July 22, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025-K116-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Digital intervention has a high blood pressure in the high-risk population of stroke Study on the effect of stress on self-management behavior of patients

Subscribe